AAV-mediated liver-directed gene therapy for Acute Intermittent Porphyria: It is safe but is it effective? (2016)

First Author: Brunetti-Pierri N
Attributed to:  Overcoming immunological barriers to regenerative medicine funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jhep.2016.07.006

PubMed Identifier: 27422751

Publication URI: http://europepmc.org/abstract/MED/27422751

Type: Journal Article/Review

Volume: 65

Parent Publication: Journal of hepatology

Issue: 4

ISSN: 0168-8278